Ember Health
Alison Greenberg is an accomplished healthcare entrepreneur and growth strategist with extensive experience in founding and leading innovative companies. Currently serving as Senior Director of Growth & Partnerships at Ember Health, Alison previously co-founded and led Ruth Health as CEO, providing virtual maternity care to enhance health outcomes across various healthcare systems. Additionally, Alison co-founded Dioptra Co, which developed a patent-pending medical device aimed at improving OB/GYN patient comfort. Prior consulting work included directing brand strategy for notable organizations such as McCann and Pfizer. Alison also co-founded aflow, a studio focused on AI-powered conversational experiences. Educational credentials include a BA in Anthropology from Yale University and participation in the Y Combinator S21 Batch.
This person is not in any teams
This person is not in any offices
Ember Health
We provide safe, effective ketamine therapy for people seeking relief from depression We founded Ember Health because we were frustrated by the lack of effective medical treatment options for the millions of people struggling with severe depression. We know we share this feeling with the thousands of compassionate mental healthcare professionals who provide critical counsel to their patients. They desire better, more reliable complements to their care. We believe ketamine is a powerful answer to this need: Whereas fewer than 30% of patients on traditional antidepressants realize relief of their depressive symptoms, low-dose infusions of ketamine have shown an average of 75% improvement in depression. While oral antidepressant medication can take six to eight weeks to take effect and have unwanted side effects, ketamine takes effect almost immediately after administration, with minimal, if any, harmful effect. Join as at https://emberhealth.co/ to learn more.